Pharmafile Logo

responsive web design (RWD)

- PMLiVE

Jazz Pharma’s SCLC drug fails to meet primary endpoint in combo trial

Drug combination failed to improve overall survival rate

11 London - Migraine-friendly colours

Migraine-friendly colours for the home

You may not realise it, but colour impacts migraines. 11 London worked with Teva Pharmaceuticals UK, Dulux Paints and the National Migraine Centre to test this theory among 1,200 migraine...

11 London

- PMLiVE

How can virtual pharma companies de-risk new product launches?

The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market

- PMLiVE

Moderna expects to supply 125 million COVID-19 vaccine doses in Q1 2021

85 million to 100 million doses will be available in the US

- PMLiVE

Merck KGaA signs deal with Artios Pharma potentially worth up to $860m

Three-year collaboration agreement will seek to develop a range of therapeutic candidates

- PMLiVE

NIAID chief back-pedals on criticism of UK’s Pfizer vaccine approval process

Anthony Fauci apologised for previous comments in BBC interview

The Future of Wearable and Implantable Devices

Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....

Impetus Digital

Designing Ethical AI and Healthcare Technologies

Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...

Impetus Digital

https://youtu.be/5jUf-4v_g7w

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

Impetus Digital

- PMLiVE

Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM

Editorial highlights issues with WHO’s Solidarity trial

Bayer symbol

Bayer strengthens cell and gene therapy focus with new platform

Platform builds on previous acquisition deals for AskBio and BlueRock

- PMLiVE

Not waving but drowning. Reflections on data curation in the age of information overload

As of October 2019 there were over 300,000 clinical studies registered worldwide, compared to just over 2,100 in the year 2000’It’s common to hear colleagues and friends bemoan the huge...

Porterhouse Medical Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links